Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Apr 24;24(5):588-597.
doi: 10.1093/ehjci/jead009.

A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation

Affiliations
Observational Study

A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation

Gregor Heitzinger et al. Eur Heart J Cardiovasc Imaging. .

Abstract

Aims: Secondary tricuspid regurgitation (sTR) is the most frequent valvular heart disease and has a significant impact on mortality. A high burden of comorbidities often worsens the already dismal prognosis of sTR, while tricuspid interventions remain underused and initiated too late. The aim was to examine the most powerful predictors of all-cause mortality in moderate and severe sTR using machine learning techniques and to provide a streamlined approach to risk-stratification using readily available clinical, echocardiographic and laboratory parameters.

Methods and results: This large-scale, long-term observational study included 3359 moderate and 1509 severe sTR patients encompassing the entire heart failure spectrum (preserved, mid-range and reduced ejection fraction). A random survival forest was applied to investigate the most important predictors and group patients according to their number of adverse features.The identified predictors and thresholds, that were associated with significantly worse mortality were lower glomerular filtration rate (<60 mL/min/1.73m2), higher NT-proBNP, increased high sensitivity C-reactive protein, serum albumin < 40 g/L and hemoglobin < 13 g/dL. Additionally, grouping patients according to the number of adverse features yielded important prognostic information, as patients with 4 or 5 adverse features had a fourfold risk increase in moderate sTR [4.81(3.56-6.50) HR 95%CI, P < 0.001] and fivefold risk increase in severe sTR [5.33 (3.28-8.66) HR 95%CI, P < 0.001].

Conclusion: This study presents a streamlined, machine learning-derived and internally validated approach to risk-stratification in patients with moderate and severe sTR, that adds important prognostic information to aid clinical-decision-making.

Keywords: HFmrEF; HFpEF; HFrEF; machine learning; secondary tricuspid regurgitation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
Variable importance analysis in moderate (A) and severe sTR (B) patients. Investigation of variable importance in two random survival forest models, encompassing a broad spectrum of clinical, echocardiographic and laboratory variables. The five most predictive variables consisted of serum albumin, Nt-proBNP, hemoglobin, glomerular filtration rate and C-reactive protein. AFIB = atrial fibrillation, BMI = body mass index, COPD = chronic obstructive pulmonary disease, hs-CRP = high sensitivity C-reactive protein, HF = heart failure, GFR = glomerular filtration rate, WBC = white blood cell count.
Figure 2
Figure 2
Partial dependency plots in moderate sTR RSF model. Partial dependency plots of the five most predictive variables (A–E) to investigate potential non-linear associations with risk-adjusted mortality at 6 years in patients with moderate sTR. Optimal thresholds for each parameter are denoted by dashed line. Hs-CRP = high sensitivity C-reactive protein, GFR = glomerular filtration rate.
Figure 3
Figure 3
Partial dependency plots in severe sTR RSF model. Partial dependency plots of the five most predictive variables (A–E) to investigate potential non-linear associations with risk-adjusted mortality at 6 years in patients with severe sTR. Optimal thresholds for each parameter are denoted by dashed line. Hs-CRP = high sensitivity C-reactive protein, GFR = glomerular filtration rate.
Figure 4
Figure 4
Prognostic impact according to the number of adverse features. The most important predictors were identified and patients stratified according to their number of adverse features. Kaplan-Meier analysis shows excellent risk-stratification in patients with moderate sTR (derivation cohort Figure 4/Plot A and validation cohort Figure 4/Plot B) and in severe sTR (derivation cohort Figure 4/Plot C and validation cohort Figure 4/Plot D).

References

    1. Topilsky Y, Maltais S, Medina Inojosa J, Oguz D, Michelena H, Maalouf Jet al. . Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging 2019;12:433–42. - PubMed
    1. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs Jet al. . ESC/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021;2021.
    1. Antunes MJ, Rodriguez-Palomares J, Prendergast B, De Bonis M, Rosenhek R, Al-Attar Net al. . Management of tricuspid valve regurgitation: position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Surg 2017;52:1022–30. - PubMed
    1. Bartko PE, Arfsten H, Frey MK, Heitzinger G, Pavo N, Cho Aet al. . Natural history of functional tricuspid regurgitation: implications of quantitative Doppler assessment. JACC Cardiovasc Imaging 2019;12:389–97. - PubMed
    1. Spinka G, Bartko PE, Heitzinger G, Prausmuller S, Pavo N, Frey MKet al. . Natural course of nonsevere secondary tricuspid regurgitation. J Am Soc Echocardiogr 2021;34:13–19. - PubMed

Publication types